Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document explains various skin conditions in cats and how to diagnose and treat them.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.